Quimioembolización transarterial con partículas liberadoras de doxorrubicina frente a quimioembolización transarterial convencional en carcinomas hepatocelulares irresecables: un estudio de eficacia, seguridad y gastos-Reference-Cited by-同舟云学术

Quimioembolización transarterial con partículas liberadoras de doxorrubicina frente a quimioembolización transarterial convencional en carcinomas hepatocelulares irresecables: un estudio de eficacia, seguridad y gastos

Published:2015-11 Issue:6 Volume:57 Page:496-504
ISSN:0033-8338
Container-title:Radiología
language:es
Short-container-title:Radiología

Author:

Megías Vericat J.E.,García Marcos R.,López Briz E.,Gómez Muñoz F.,Ramos Ruiz J.,Martínez Rodrigo J.J.,Poveda Andrés J.L.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference36 articles.

1. Prognostic factors for survival in patients with early intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre;Grieco;Gut.,2005

2. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;Llovet;J Hepatol.,2012

3. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial;Llovet;Lancet.,2002

4. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma;Lo;Hepatology.,2002

5. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival;Llovet;Hepatology.,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial);CardioVascular and Interventional Radiology;2024-02-27

2. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-02

3. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

4. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-01

5. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01